Advance purchase commitments from AVEVA, Bain & Company, Google, McKinsey, and others support Infinium's Project Atlas, a Texas-based planned facility expected to produce up to 100,000 metric tons of high-integrity sustainable aviation fuel per year.

WASHINGTON, Sept. 22, 2026 /PRNewswire/ -- The Sustainable Aviation Buyers Alliance (SABA) today announced commitments from members to purchase sustainable aviation fuel certificates (SAFc) associated with Infinium Energy's Project Atlas, an eSAF facility expected to produce approximately 100,000 metric tons of SAF annually, providing the long-term structured contracts that are catalytic to securing project financing.

The groundbreaking results of SABA's latest procurement were supported by leading member organizations, including AVEVA, Bain & Company, Google, McKinsey, and others, and mark an important addition to SABA's market model. Through exclusive focus on supporting projects toward final investment decision, this procurement represents a first-ever application of SABA's approach to drive new production of highly scalable, high-integrity SAF. Infinium submitted its winning proposal jointly with American Airlines, which will take physical delivery of the fuel and oversee fuel logistics. Contracted volumes under these agreements are expected to support greenhouse gas abatement of over 212,000 mtCO2e, equivalent to the emissions of over 3,500 JFK to LAX commercial flights.

"Reducing emissions from business travel is an important part of our sustainability efforts," said Isabelle Schuhmann, Global Director of Environmental Sustainability at McKinsey. "By supporting next-generation sustainable aviation fuel, this purchase helps advance a promising solution for decarbonizing aviation at scale, while enabling the travel that is essential to serving our clients."

Aviation currently accounts for approximately 2-3% of global greenhouse gas emissions, yet SAF supply remains limited and at a significant premium to conventional jet fuel. Infinium, which was selected through SABA's procurement process earlier this year, produces ultra-low carbon eSAF at commercial scale using waste CO₂ and renewable energy, converting captured carbon into drop-in aviation fuel compatible with existing aircraft and infrastructure.

"We're proud to partner with SABA members including AVEVA, Bain & Company, Google, McKinsey, and others, as well as American Airlines to bring Infinium Energy's next world scale eSAF facility to life," said Robert Schuetzle, CEO at Infinium. "Their commitment reflects a shared conviction that decarbonizing aviation requires real investment in next-generation supply."

"The companies purchasing SAF certificates through this agreement are demonstrating the leadership needed to help scale a critical solution for aviation," said American's Chief Sustainability Officer Jill Blickstein. "Their commitments broaden participation in the SAF market, support investment in new production and show how customers can work alongside airlines and fuel producers to advance aviation decarbonization."

SABA procurements use a book and claim model that allows corporate customers to invest in SAF and claim the associated environmental benefits, even when the fuel does not flow directly into the planes their employees or freight fly on. Participating companies purchase SAFc, while the corresponding fuel is delivered to an aircraft operator. American Airlines will serve as the physical offtaker for the SAF purchased through this deal and facilitate the allocation of the associated Scope 3 emission reductions to SABA's participating members.

"Next-generation sustainable aviation fuels have tremendous potential to transform aviation," said Sam Israelit, Chief Sustainability Officer at Bain & Company. "High-integrity market mechanisms can help translate corporate demand into the long-term investment signals needed to bring these technologies to commercial scale."

While the SAF market is growing rapidly, more investment is needed, especially for the next generation technologies the aviation sector requires to meet its long-term decarbonization goals. SABA helps accelerate future supply by aggregating SAF demand from corporate buyers and channeling it into offtake agreements with SAFc suppliers who meet rigorous sustainability criteria. SABA's next generation SAF procurement was specifically designed to drive investment into the innovative new technologies needed to bring scalable supply to the market in the years to come.

"Long-term, bankable offtake is often the missing puzzle piece that keeps new SAF plants from getting financed and built," said Kim Carnahan, GMA CEO and Head of SABA Secretariat. "We're thrilled to be working with our SABA members, Infinium, and American Airlines to fill this need and help get more ultra-low carbon aviation fuel to the market."

"We already know innovation can take us much further, faster, but only if we create the conditions for it to scale," said Jon Creyts, CEO of RMI. "Novel technologies are critical to meeting future demand for sustainable aviation fuel, but they will not be operational in time without investments made today. This procurement demonstrates how aggregated, long-term demand can help take promising eSAF projects from idea to reality."

To date, SABA has aggregated $500 million in demand for SAFc from over 35 member companies, driving needed investment toward sustainable aviation fuels. SABA's procurements are supported by robust market infrastructure, including the SAFc Registry, SAFc Accounting and Reporting Guidance, and SABA's Sustainability Framework. Combined, these tools ensure high-integrity transactions across the market. Recent guidance from standard setting organizations, including the Science-based Targets initiative, has recognized environmental attribute certificates from book and claim systems, like SAFc, as a legitimate tool for decarbonizing hard-to-abate value chain emissions.

With the binding, multi-year offtake agreements from SABA customers in hand, Infinium is well positioned to advance to final investment decision and secure financing to build the facility. In addition to serving voluntary customers, Infinium also plans to sell RFNBO compliant eSAF from the facility into European regulatory markets.

"eFuels represent one of the most sustainable pathways to help decarbonize aviation — but they are more expensive to produce," said Fred Krupp, president of Environmental Defense Fund. "Deals like this one prove that high-integrity e-SAF is investable today, not just in theory. The next test is turning early demand signals like SABA's into the long-term policy and financing conditions that will enable e-SAF suppliers to scale beyond a single project."

Plans for SABA's next procurement are already underway, offering future opportunities for companies to purchase and apply SAFc to their climate targets.

Media inquiries please contact:

Alison Greene, Communications Manager [email protected]

About the Sustainable Aviation Buyers Alliance (SABA)

The Sustainable Aviation Buyers Alliance (SABA) is a joint initiative of Environmental Defense Fund, the Center for Green Market Activation (GMA) and RMI focused on accelerating the path to net-zero aviation by driving investment in, and adoption of, high-integrity sustainable aviation fuel (SAF) and supporting companies, airlines, and freight customers in achieving their climate goals. More information on SABA can be found at www.flysaba.org or follow us on LinkedIn.

About Infinium

Infinium is reimagining how the world powers, moves, and computes. Through Infinium Energy™, the company transforms waste carbon into ultra-low carbon eFuels that decarbonize aviation, industry, and transport. Through Infinium Edge™, Infinium advances next-generation thermal infrastructure for data centers, removing heat as a constraint to enable more efficient, high-performance computing. Grounded in deep chemistry and energy systems expertise, Infinium's platforms turn carbon and heat from limits into opportunities.

About American Airlines Group (NASDAQ: AAL)

American Airlines is a premium global airline connecting more of the U.S. to the world. With roots tracing back to an air mail carrier in the Midwestern United States in 1926, American now operates more than 6,000 daily flights to more than 350 destinations in more than 60 countries and serves more than 200 million customers annually. Powered by a proud and talented team of 130,000 aviation professionals, American's team lives out the airline's purpose of caring for people on life's journey every day.

The world's largest airline proudly celebrates its centennial year in 2026, reaching a milestone that reflects a century of innovation and the Forever Forward℠ spirit that changed the industry and the world. American introduced the first scheduled air cargo service, the first airport lounge and the first airline loyalty program and continues to reinvent the customer experience today. The airline is also a founding member of the oneworld alliance, whose members serve more than 900 destinations around the globe.

Get the latest about American at news.aa.com and @AmericanAir.

SOURCE Sustainable Aviation Buyers Alliance

Share this article

Company experts will deliver sessions on government pricing policy, 340B, gross-to-net strategy, and trade and distribution trends across three premier industry events this fall

PHILADELPHIA, Sept. 22, 2026 /PRNewswire/ -- IntegriChain, the leading provider of pharma net revenue optimization technology, data, and consulting for the life sciences industry, today announced that its subject matter experts will present at three of Informa Connect's flagship fall conferences: the Medicaid Drug Rebate Program (MDRP) Summit, the Pharma/Biotech Gross-to-Net (GTN) Summit, and Trade & Channel Strategies. Across the three events, IntegriChain leaders will share insights on government pricing and contracting, 340B, gross-to-net forecasting, and the future of pharmaceutical distribution and access.

"Government pricing, 340B, gross-to-net, and trade and channel strategy are more interconnected and more consequential than ever for our clients," said Jeff Baab, Partner, Advisory Services with IntegriChain "These conferences give our team the opportunity to bring real-world perspective from the hundreds of manufacturers we support directly to the industry."

Baab, Willis Speaks on Evolving Contracting Environment

At the Medicaid Drug Rebate Program (MDRP) Summit 2026, taking place October 5–7, 2026, at the Fairmont Chicago Millennium Park in Chicago, IL, Jeff Baab, Partner, Advisory Services at IntegriChain, will present "Updates on Landscape of Government Pricing and Contracting" on Wednesday, October 7, at 9:40 AM. Baab will share his perspective on the evolving government pricing and contracting environment, drawing on his extensive experience advising manufacturers on gross-to-net, contracting, and market access across both commercial and government channels.

340B industry expert Clay Willis, Partner, Advisory Services at IntegriChain will also present "340B Movement to Have All 340B Claims in One System of Record" on Wednesday, October 7 at 10:50 AM, while also offering an update on the recent 340B events such as the the rebate model pilot program #2, contract and in-house pharmacy policies, patient definition, plus other activities occurring in the market.

At the Pharma/Biotech Gross-to-Net (GTN) Summit 2026, taking place November 16–18, 2026, at the Hilton at Penn's Landing in Philadelphia, PA, two IntegriChain leaders will take the stage to share perspectives on the issues shaping gross-to-net strategy.

On Monday, November 16, at 4:30 PM, Jennifer Sharpe, Vice President, Gross-to-Net Consulting and Facilitator of the Revenue Analytics Collaborative at IntegriChain, will host and moderate "Hot Topic Roundtable Discussions: Sponsored by IntegriChain's Revenue Analytics Collaborative (RAC)" for RAC members. The session will bring together participants from the 800+ member industry peer network Sharpe co-founded to discuss the topics shaping GTN strategy today.

On Tuesday, November 17, at 10:55 AM, Walt Worsham, Managing Director at IntegriChain, will present "Drug Pricing Policy & Regulatory Landscape Updates," offering an update on the drug pricing policy and regulatory developments most relevant to gross-to-net forecasting, accruals, and contracting strategy.

At Trade & Channel Strategies 2026, taking place December 8–10, 2026, at the W Hotel in Philadelphia, PA, Bill Roth, Senior Vice President and Managing Partner, Consulting and Advisory at IntegriChain, will deliver a keynote address on the state of the channel. His remarks will examine the disruption facing today's pharmacy and distribution landscape, from reimbursement pressure at national retail chains to the downstream effects on specialty and general medicine brands.

For more insights on government pricing, 340B, and gross-to-net strategy from IntegriChain's team, visit www.integrichain.com or follow IntegriChain on LinkedIn.

About IntegriChain

IntegriChain delivers biopharma's only comprehensive data-driven commercialization platform from strategy to operational execution connecting the commercial, financial, and operational dimensions of drug access and profitability. Our ICyte® platform integrates technology, data, consulting, and managed services to unify critical workflows replacing manual processes with integrated analytics and precision controls.

Biopharma relies on IntegriChain to optimize patient access and net revenue performance, reduce leakage, and strengthen compliance, ensuring every life-changing therapy reaches patients with speed, affordability, and sustainability. Backed by Nordic Capital, a leading sector-specialized private equity investor with a broad portfolio in healthcare and technology. IntegriChain is headquartered in Philadelphia, PA, with a location in Pune, India. For more information, visit www.integrichain.com or follow us on LinkedIn.

For more information, visit www.integrichain.com.

Media Contact

Brandy Jensen, Senior Director Marketing, IntegriChain

SOURCE IntegriChain, Inc.

Share this article

Pomelo Care Shares New Data Demonstrating Reduced NICU Utilization, Lower Infant Healthcare Costs, and Improved Quality of Care Through Its Virtual Maternity Care Model

Claims-Based Data Shows Significant Improvements in HEDIS Quality Measures, 45% Shorter NICU Stays, and Over $9,000 in Cost Savings, Including a 20% Reduction in Infant Healthcare Costs

NEW YORK, Sept. 22, 2026 /PRNewswire/ -- Pomelo Care, the national leader in evidence-based healthcare for women and children, presented new data at the 2026 annual meetings of the American College of Obstetricians and Gynecologists (ACOG), The Professional Society for Health Economics and Outcomes Research (ISPOR), and the AcademyHealth Annual Research Meeting (ARM). The findings build on Pomelo's robust body of research, including over 40 peer-reviewed studies demonstrating that proactive, technology-enabled maternity care can improve maternal and neonatal outcomes, reduce healthcare utilization and costs, close critical care gaps, and deliver measurable value for employers and health plans. The findings are drawn from medical claims data, not patient surveys, making Pomelo's results auditable within the same datasets employers and health plans use to track healthcare spend.

The new data demonstrates that Pomelo's virtual care model improves outcomes and reduces healthcare costs across the maternity lifecycle, from prenatal care and NICU utilization through postpartum and infant care. Collectively, the studies found that Pomelo's care model was associated with:

- 45% shorter NICU stays

- 63% reduction in NICU-related costs per delivery

- $9,038 lower average total episode cost

- 20% reduction in total infant healthcare costs

- 10% reduction in infant emergency department costs

- 82% increase in the odds of Timeliness of Prenatal Care (TOPC), as defined by HEDIS

- 47% increase in the odds of Timely Postpartum Care (PPC), as defined by HEDIS

"Employers and health plans are looking for clear evidence that clinically integrated, evidence-based maternity care can improve outcomes while meaningfully reducing costs," said Marta Bralic Kerns, founder and CEO of Pomelo Care. "Pomelo's extensive body of research continues to show that when care is proactive, continuous, and coordinated across pregnancy, postpartum, and infancy, it can reduce complications, lower NICU utilization and emergency care, close critical gaps in maternal care, and deliver measurable value for families and payers alike."

At ACOG, Pomelo presented new data evaluating the impact of proactive virtual maternity support on NICU utilization and maternity episode costs. The analysis compared outcomes for patients who enrolled in Pomelo's program prenatally with a comparison group of patients who enrolled only after delivery, helping isolate the impact of the clinical intervention from a patient's propensity to engage with care. The study found that prenatal engagement with Pomelo was associated with a 45% shorter NICU length of stay, a 63% reduction in NICU-related costs per delivery, and a $9,038 lower average total episode cost. These findings suggest that proactive virtual support layered onto standard prenatal care may help reduce NICU utilization and associated healthcare costs.

At ISPOR, Pomelo presented new data evaluating how early pregnancy identification combined with proactive virtual gap closure can improve HEDIS quality metrics tied to payer reimbursement and accreditation. The analysis examined a virtual maternity program powered by a proprietary identification engine that uses multiple data sources to identify pregnancy early in gestation and connect patients to timely clinical support. It found that the program was associated with an 82.3% increase in the odds of Timeliness of Prenatal Care (TOPC) and a 46.7% increase in the odds of Postpartum Care (PPC). Researchers estimated that, when applied to the Texas Medicaid Pay for Quality Program, these improvements could secure between $2 million and $6 million in quality-based reimbursement for a single mid-sized health plan. These findings show the potential of proactive virtual maternity care to help health plans improve quality performance and close critical gaps in maternal care.

At ARM, Pomelo presented data evaluating the association between engagement in its virtual maternity and infant care program and infant health care costs during the first 60 days of life. It examined more than 9,500 infants and found that engagement with Pomelo's program was associated with a 20.65% reduction in total infant healthcare costs and a 10.24% reduction in infant emergency department costs. It showed that continuous access to Pomelo's multidisciplinary care team, including pediatric providers, nurses, lactation consultants, and mental health specialists, may help families address acute neonatal concerns earlier and reduce avoidable emergency department utilization.

This builds on Pomelo's robust body of evidence, including its flagship study published earlier this year in Pregnancy, which found that longer prenatal engagement with Pomelo was associated with progressively greater reductions in preterm birth, NICU utilization, and healthcare costs.

About Pomelo Care

Pomelo Care is the national leader in evidence-based healthcare for women and children. We deliver personalized, high-quality clinical interventions from reproductive care and pregnancy, infant care and pediatrics, to hormonal health through perimenopause and menopause, with long-term preventive care and condition management. Our model delivers 24/7 multispecialty care to address the medical, behavioral, and social factors that most significantly impact outcomes for women and children. We partner with payers, employers, and providers to expand access to quality healthcare across the system. Learn more at pomelocare.com.

Media Contact

Julie Halpin

[email protected]

SOURCE Pomelo Care

Share this article

SAN FRANCISCO, Sept. 22, 2026 /PRNewswire/ -- Superpower today announced a new partnership with Sequoia to bring a more proactive model of preventive health to employers and their teams. The partnership will begin with Sequoia's own 800+ employee workforce, giving Sequoia firsthand experience with Superpower while simultaneously making the solution available to eligible client organizations across its employer ecosystem.

Employer healthcare often starts after something has already gone wrong. Symptoms appear. A diagnosis is made. Risk shows up as a claim. Superpower is working to shift that experience earlier, helping people better understand their health before issues become more serious and helping employers support preventive care in a more meaningful way.

The partnership with Sequoia is designed to make that model easier for employers to evaluate and adopt. Sequoia works with more than 2,500 companies and reaches more than 600,000 people, giving it a broad view into the challenges employers face as they manage rising healthcare costs, fragmented benefits, and growing demand for more personalized employee support.

Many people want to be more proactive about their health, but the current system can make that difficult. Annual visits often rely on limited testing and provide only a snapshot in time. Health records may be spread across providers, apps, and systems. New technology can make guidance more personalized, but it works best when connected to comprehensive data and clinical support.

Superpower turns a simple blood draw into an ongoing preventive health experience. Members receive 150+ biomarker testing at home, at thousands of lab locations, or onsite. They also receive a longitudinal health profile that can combine labs, health records, and wearable data, along with a personalized action plan, 24/7 Health AI, licensed clinical support, proactive outreach, and retesting to track progress over time. When the data points to care or a benefit an employer already offers, Superpower helps the member understand where to go next.

By partnering with Sequoia, Superpower can bring this experience to an employer audience that is actively looking for more proactive, integrated ways to support workforce health. Sequoia will begin by offering Superpower to its own employees, then use that experience to advise eligible clients that are evaluating comprehensive preventive health as part of their broader benefits strategy.

"Most people are trying to make health decisions with limited information and a fragmented view of their health. Superpower brings together comprehensive testing, technology, and clinical support so people can better understand what is happening in their bodies and take action earlier. Partnering with Sequoia helps us bring that model to employers in a thoughtful, credible way, starting with Sequoia's own team," said Max Marchione, Chief Executive Officer at Superpower.

Sequoia's decision to begin with its own workforce reflects the way many employers are approaching new health solutions: they want to understand the employee experience, the operational requirements, and the potential value before recommending or scaling them more broadly.

"Employers have made significant investments in healthcare, but much of that support begins after a condition is already known. We see an opportunity to help people engage earlier, with better information and clearer next steps. By offering this to our own team, we can learn firsthand what this experience delivers and help clients evaluate whether it fits into their broader preventive health strategy," said Christina Sullivan, Chief Client Officer at Sequoia.

Health costs continue to rise, and employers often have limited visibility into health risks before they become more serious and more expensive. Through this partnership, Superpower and Sequoia aim to help employers move upstream, supporting people earlier, connecting them with appropriate care, and making better use of the benefits already available to them.

Eligible Sequoia client organizations should reach out to their Sequoia representative for more information.

About Superpower

Superpower has quickly become one of the most trusted names in preventive healthcare. The company has raised more than $40 million in funding, with its Series A led by Forerunner Ventures. Its membership combines comprehensive lab testing across 150+ biomarkers, AI-powered insights, personalized protocols, and 24/7 access to a clinical care team. The platform brings together each member's test results with their broader health context - including previous labs, real-time wearable data, family history, and conversations with Superpower AI - to uncover trends, surface potential risks, and deliver ongoing guidance that evolves alongside them. For further information, visit www.superpower.com.

About Sequoia

Sequoia is the strategic partner helping investor-backed companies of all sizes achieve their business goals through smarter people spend. For over 25 years, we've guided the most innovative employers to navigate growth and get the most out of their global people investment. With our expert advisory team and integrated platform, we help clients drive business impact through their total comp and benefits, improving executive decision making, controlling costs, protecting the business, and elevating the employee experience. Visit Sequoia.com or follow us on LinkedIn to learn more.

SOURCE Superpower

Share this article

Tres Locos Mexican food is now available hot at the touch of a button.

DENVER, Sept. 22, 2026 /PRNewswire/ -- Tres Picosos, known for its authentic approach to Mexican cuisine, announces its partnership with Evolvending, a leader in automated dining across U.S. airports. The company's crazy good Mexican food brand, Tres Locos, currently operates a kiosk at the Minneapolis-St. Paul International Airport (MSP) Terminal 1, Concourse G, which serves the prominent carrier Delta Air Lines.

In addition to Tres Picosos' footprint in QSR, convenience, and grocery channels, airport travelers will now have round-the-clock access to hot, authentic Mexican food at the touch of a button. The Tres Locos kiosk features its most in-demand burritos, including Bacon Breakfast, Chicken Fajita, Picadillo Beef, and Pork Carnitas, as well as street-style tacos.

"It's bueno to be entering this new and exciting marketplace," said Jane Hartgrove, la jefa (Spanish for "the boss") at Tres Picosos. "The Evolvending concept fills an important need when convenience is essential, and enjoyment is valued. Now, customers can get delicious Mexican food exactly how and when they want it — hot and ready — even when the rest of the world is closed."

According to Vending Times, the hot food vending machine industry in the U.S. and Canada is predicted to reach $9.6 billion by 2036, up from $5.5 billion in early 2026. Tres Picosos plans to build on this growth with additional airports planned in the coming months.

Tres Locos is also available at current EvolveCAFÉ locations, including Boston Logan International Airport (BOS), Charleston International Airport (CHS), Southwest Florida International Airport (RSW), reflecting the company's strategy to offer travelers a diverse mix of premium dining options spanning breakfast, lunch, dinner, snacks and fresh food concepts.

"One of the strengths of our platform is our ability to bring together a diverse portfolio of brands that reflects how travelers want to eat today," said Valentina Ellison, CEO of Evolvending. "Tres Locos is a fantastic brand that delivers authentic, high-quality Mexican cuisine. We're excited to add one of America's favorite food categories to our platform while giving our airport partners even greater flexibility to meet evolving traveler preferences."

To find exact machine placements, visit the Evolvending Locations directory.

About Tres Picosos

Made in Colorado, Tres Picosos — translated as "three hotties" or "spicy peppers" — has been producing authentic Mexican food since 2005. Uncompromising on quality ingredients and committed to bringing affordable, gourmet-level Mexican food to U.S. retailers, Tres Picosos makes branded and private-label burritos plus an entire Mexican foodservice platform through its Naughty Chile Taqueria, Tres Locos, and Saluda brands. Tres Picosos is a woman-owned business (WBENC) with nationwide distribution through Dot Foods, Inc. and KINEXO. To learn more, visit: www.trespicosos.com.

About Evolvending

Evolvending is a leader in modern automated retail, delivering innovative, self-service food and beverage solutions designed for today's on-the-go travelers for major airports and transit hubs nationwide—including key markets such as Boston Logan (BOS), Minneapolis-St. Paul, Cincinnati/Northern Kentucky (CVG), Southwest Florida (RSW), among others. Through exclusive partnerships with top national brands and custom culinary concepts, Evolvending bridges the gap between traditional airport concessions and modern automated retail, delivering frictionless, high-quality dining options for travelers on the go. By blending smart hardware, intuitive software, and data-driven operations, the company enables fresh, premium hot and cold food availability around the clock. For more information, visit evolvending.com.

SOURCE Tres Picosos

Share this article

New guide helps security leaders evaluate identity security platforms against evolving threats.

CENTREVILLE, Va., Sept. 22, 2026 /PRNewswire/ -- ID Dataweb™, a recognized leader in identity threat detection and risk mitigation, today announced the release of its new buyer's guide, "Identity Threat Detection & Risk Mitigation," designed to help executive and senior security leaders evaluate how to protect their organizations against identity-based attacks and account-related threats.

As identity attacks grow more sophisticated and extend across customers, third parties, and workforce identities, organizations face an increasingly complex technology landscape. ID Dataweb's new guide challenges security leaders to look beyond traditional vendor comparisons and feature checklists and instead evaluate whether identity security solutions can operate as a cohesive, end-to-end platform.

"Identity threats don't exist in silos, and organizations can no longer afford to defend against them with disconnected tools and fragmented intelligence," said Dr. Torsten George, Chief Cybersecurity Evangelist at ID Dataweb. "This guide is intended to give security leaders a more practical framework for evaluating identity threat detection — one that focuses not simply on what individual products can do, but on how effectively an organization can detect risk, orchestrate decisions, and respond across its entire identity lifecycle."

The guide comes as several developments reshape the identity threat landscape. AI has made sophisticated fraud techniques such as deepfakes, synthetic documents, and social engineering more accessible. Compromised credentials are widely available, diminishing the value of credentials alone as a signal of legitimacy. At the same time, attackers increasingly target workforce, third-party and help desk access pathways in addition to traditional customer-facing channels.

Research from CIO Dive's Studio in partnership with ID Dataweb found that 82% of security leaders recognize identity as the new security perimeter, yet only 17% are extremely confident in their ability to detect identity-based threats. Fragmentation remains a significant challenge, with 43% identifying fragmented identity systems as their top obstacle.

A Framework for Evaluating Identity Threat Detection

Rather than treating every feature as equally important, the buyer's guide identifies several areas where architectural depth can make a meaningful difference in real-world security outcomes. It encourages organizations to evaluate vendors based on:

- Risk orchestration: The ability to combine authoritative identity sources and risk signals into policy-driven decisions in real time.

- Coverage across attack vectors: Protection spanning customer, third-party, and workforce identities rather than a single population.

- Service resilience and fallback: Automatic failover and alternative verification methods that maintain protection when a primary service is unavailable.

- Privacy and data residency: The ability to correlate identity risk while minimizing the storage of personally identifiable information and supporting regulatory requirements.

- Synthetic identity and data hygiene: Continuous reanalysis of existing user records to identify potentially fraudulent identities that point-in-time verification may miss.

- Expert human support: Identity fraud expertise that complements automated detection and continuously informs detection logic.

The guide also addresses the different priorities stakeholders bring to the buying process. For CISOs, that includes real-time threat detection, adaptive policy enforcement, and compliance-ready reporting. Identity fraud leaders need higher-confidence determinations, broader risk signals, and fewer false positives. CIOs and IT executives need API-first technology that integrates with existing IAM and SIEM infrastructure while reducing the operational burden created by multiple point solutions.

Ultimately, the guide recommends that organizations design proofs of concept to test how well an identity security platform operates as a cohesive whole — not simply whether a vendor can check individual boxes on a feature list.

"Identity Threat Detection & Risk Mitigation" is available now at www.iddataweb.com.

About ID Dataweb

ID Dataweb™ helps enterprises stay ahead of identity fraud and account-related threats with real-time detection and mitigation while maintaining a seamless experience for their workforce, third parties, and customers. The ID Dataweb SaaS platform combines adaptive identity verification methods, behavioral analytics, device and credential intelligence, and risk scoring. Backed by AI and expert insights, these capabilities proactively stop identity-based attacks, protect revenue, and strengthen compliance. Unlike static legacy identity tools, ID Dataweb delivers dynamic, multi-layered risk orchestration that adapts to evolving threats. Its low-code, cloud-native services deploy quickly, integrate seamlessly with existing IAM systems, and align with each customer's policies.

For more information, please visit www.iddataweb.com.

Media Contact:  

Larry Smalheiser  

WOC | Signal

[email protected]

SOURCE ID Dataweb

Share this article

Monthlong celebration of Wisconsin heritage also features return of Jalapeño Cheese Curds and National Cheese Curd Day festivities

Summary:

- Curdtoberfest™ returns for its second year, transforming October into a celebration of Wisconsin heritage, Midwest hospitality and the cheese curds that have become synonymous with Culver's.

- Culver's Smoked Cheddar CurderBurger ®, the brand's first flavored CurderBurger since its 2021 debut, hits menus from Sept. 28 through Oct. 11, or while supplies last.

- Fan-favorite Jalapeño Cheese Curds return Oct. 12 through Nov. 29 while supplies last, for a spicy twist on Culver's iconic Wisconsin Cheese Curds.

- All Culver's restaurants will celebrate National Cheese Curd Day on Oct. 15 with Happy Hour, when Delicious Rewards members can enjoy discounted $3 cheese curds from 4:00 – 8:00 p.m. local time.

- Guests who visit culvers.com/curdtoberfest from Sept. 28 through Oct. 31 can play games and enter the Curdtoberfest Sweepstakes for a chance to win a grand prize trip for four to Germany or additional prizes, including $2,000 cash, weekly $500 prize packs and instant-win rewards.

PRAIRIE DU SAC, Wis., Sept. 22, 2026 /PRNewswire/ -- Culver's is inviting guests to gather round for the return of Curdtoberfest, its annual monthlong celebration honoring Wisconsin's heritage, rich traditions and the gooey, golden cheese that brings people together.

Leading this year's festivities is the debut of the Smoked Cheddar CurderBurger, the brand's first flavored CurderBurger, alongside the return of Jalapeño Cheese Curds, National Cheese Curd Day celebrations and a monthlong Curdtoberfest Sweepstakes experience running from Sept. 28 through Oct. 31.

The Smoked Cheddar CurderBurger features Culver's fresh, never-frozen beef topped with a crown of golden-fried smoked cheddar cheese, creating a distinctive flavor profile that builds on the craveability fans have come to expect from the limited-time favorite. It will be available from Sept. 28 through Oct. 11, or while supplies last, followed by the fan-favorite Jalapeño Cheese Curds' return on Oct. 12. A spicy spin on Culver's classic Wisconsin Cheese Curds, Jalapeño Cheese Curds are made with real cheddar cheese and bits of jalapeño pepper and will be available through Nov. 29, or while supplies last.

Founded by Culver's, National Cheese Curd Day returns on Oct. 15; all restaurants will celebrate by offering Delicious Rewards members $3 cheese curds during Happy Hour (4:00 – 8:00 p.m. local time).

"The best celebrations bring people together, and that's exactly what Curdtoberfest is all about," said Emily Patterson, vice president of marketing at Culver's. "It's inspired by the traditions we grew up with here in Wisconsin, where great food and time together go hand in hand. Whether trying our new take on the CurderBurger, sharing an order of Jalapeño Cheese Curds or celebrating National Cheese Curd Day with us, we hope Curdtoberfest gives guests a reason to gather round and experience a little Midwest magic."

To learn more about Curdtoberfest or to enter the Curdtoberfest Sweepstakes for a chance to win a grand prize trip for four to Germany, visit culvers.com/curdtoberfest.

About Culver's:

For over 40 years, Culver's guests have been treated to cooked-to-order food made with farm-fresh ingredients and served with a smile. The ever-expanding franchise system now numbers over 1,050 family-owned and operated restaurants in 26 states. The restaurants' nationally recognized customer service is based on small-town, Midwestern values, genuine friendliness and an unwavering commitment to quality. Signature items include the award-winning ButterBurger, made from fresh, never frozen beef, and Fresh Frozen Custard, including the famous Flavor of the Day program. For more information, visit www.culvers.com or connect with Culver's on Facebook, Instagram and TikTok.

CONTACT

Cody Amble

[email protected]

608-256-6357

SOURCE Culver's

Share this article

RWD/RWE for Data Platforms, Technology Solutions, and Consulting Services 2026 Vendor Assessment

AUSTIN, Texas, Sept. 22, 2026 /PRNewswire/ -- Oracle has been named a Leader in the IDC MarketScape: Worldwide Life Sciences R&D RWD/RWE for Data Platforms, Technology Solutions, and Consulting Services 2026 Vendor Assessment.1 The IDC MarketScape highlights Oracle's "long legacy for providing RWD/RWE solutions to strengthen its customers' regulatory submissions strategy, enhance their market access and reimbursement strategies, and optimize their success for product commercialization."

The report states, "[Oracle] has delivered RWD/RWE (real-world data/real-world evidence) solutions for over 40 years, aggregating real-world EHR data for nearly two decades through its health system network. It also launched an RWD platform following the 2022 acquisition of Cerner, and a next-generation AI-powered life sciences platform in 2026. Oracle works with every major pharma."

"Oracle's position reflects its long-standing experience working across healthcare and life sciences and its continued investment in AI-enabled capabilities," said Dr. Nimita Limaye, research vice president, Life Sciences R&D Strategy & Technology, IDC. "Oracle brings together real-world data, technology, and scientific and regulatory expertise within an integrated offering that can support organizations across multiple stages of the research lifecycle. With these capabilities, Oracle is uniquely equipped to help life sciences organizations maximize the value and scale of their real-world evidence."

Oracle's Approach to Real-World Data and Evidence

Oracle Life Sciences Data Intelligence integrates customer-supplied data with Oracle Health Real-World Data, which consists of more than 122 million2 de-identified, representative patient records generated through Oracle Learning Health Network. The network spans more than 255 health systems, providing a solid foundation for clinical research, regulatory evidence generation, market access, and commercialization initiatives.

The report noted, "It has out-of-the-box and customizable AI agents supporting natural language querying, cohort identification, synthetic control arm generation, health economics and outcomes research (HEOR), safety signal detection, and regulatory submission support."

"Our deep domain expertise, combined with significant investments in AI and real-world data, can help life sciences organizations make more informed decisions," said Seema Verma, executive vice president and general manager, Oracle Health and Life Sciences. "We believe this recognition from IDC MarketScape reflects our experience in real-world evidence and our commitment to helping life sciences organizations turn data into insights that can advance the development of new treatments."

To access the IDC MarketScape for Worldwide Life Sciences R&D RWD/RWE for Data, Platforms, Technology Solutions, and Consulting Services 2026 Vendor Assessment excerpt and to learn more about Oracle Life Sciences solutions, visit: https://www.oracle.com/life-sciences/real-world-data-real-world-evidence-idc-report/.

The Oracle Health and Life Sciences Summit will take place September 22–24, 2026, in Orlando, Florida. For more information, visit: https://www.oracle.com/health/health-life-sciences-summit/.

About IDC MarketScape

IDC MarketScape vendor assessment model is designed to provide an overview of the competitive fitness of technology and service suppliers in a given market. The research methodology utilizes a rigorous scoring methodology based on both qualitative and quantitative criteria that results in a single graphical illustration of each vendor's position within a given market. IDC MarketScape provides a clear framework in which the product and service offerings, capabilities and strategies, and current and future market success factors of IT and telecommunications vendors can be meaningfully compared. The framework also provides technology buyers with a 360-degree assessment of the strengths and weaknesses of current and prospective vendors.

About Oracle Life Sciences

Oracle Life Sciences is a leader in cloud technology, pharmaceutical research, and consulting, trusted globally by professionals in both large and emerging companies engaged in clinical research and pharmacovigilance, throughout the therapeutic development lifecycle, including pre- and post-drug launch activities. With more than 20 years of experience, Oracle Life Sciences is committed to supporting clinical development and leveraging real-world evidence to deliver innovation and accelerate advancements—empowering the life sciences industry to improve patient outcomes. Learn more at www.oracle.com/lifesciences.

About Oracle

Oracle offers integrated suites of applications plus secure, autonomous infrastructure in the Oracle Cloud. For more information about Oracle (NYSE: ORCL), please visit us at www.oracle.com.

Trademarks

Oracle, Java, MySQL and NetSuite are registered trademarks of Oracle Corporation. NetSuite was the first cloud company—ushering in the new era of cloud computing.

1 IDC MarketScape: Worldwide Life Science R&D RWD/RWE for Data Platforms, Technology Solutions, and Consulting Services 2026 Vendor Assessment (Doc #US54122226, August 2026)

2All data pulled from Oracle Health Data Intelligence and current as of May 2026 and calculated using distinct person IDs, which leverage a multipoint match algorithm to account for and remove duplicates within a single health system; patients who have visited multiple health systems may appear more than once in the data.

SOURCE Oracle

Share this article

Claros Technologies Announces Continued Commercial Expansion into Europe and Entry into Pharmaceutical Manufacturing with a Successful PFAS Destruction Pilot at Bachem AG

The ClarosTechUV™ PFAS Destruction System met or exceeded Bachem's established performance metrics for TFA during two weeks of testing under real-world manufacturing conditions at the company's flagship campus in Bubendorf, Switzerland

MINNEAPOLIS, Sept. 22, 2026 /PRNewswire/ -- Claros Technologies (Claros), a global leader in permanent PFAS destruction technology, today announced the successful completion of a commercial-scale pilot of its ClarosTechUV™ system at the flagship Swiss manufacturing campus of Bachem AG (Bachem) in Bubendorf, Switzerland. Bachem is one of the world's leading manufacturers of peptide and oligonucleotide active pharmaceutical ingredients (APIs), including semaglutide, the API used in blockbuster GLP-1 therapies, widely used for weight management and type 2 diabetes.

The pilot further demonstrates the broad applicability of the ClarosTechUV™ system and marks another key milestone for Claros: the successful application of ClarosTechUV™ under real-world pharmaceutical manufacturing conditions to destroy TFA at the source. The pilot also highlights the role PFAS destruction technology can play in enabling the responsible and sustainable use of PFAS substances necessary for essential applications by providing manufacturers with a solution designed to permanently destroy target PFAS in industrial wastewater.

"This relationship with Bachem represents a defining milestone for Claros and an important step forward for the global pharmaceutical industry," said Michelle Bellanca, CEO and Co-Founder of Claros Technologies. "As pharmaceutical manufacturing expands, particularly around peptide therapeutics and GLP-1 medicines, the industry is increasingly confronting how to address ultra-short-chain PFAS such as TFA in industrial wastewater. Bachem is demonstrating the kind of leadership that will define the future of pharmaceutical and industrial manufacturing by proactively deploying ClarosTechUV™ technology to destroy TFA at the source. We are incredibly proud to collaborate with one of the world's leading peptide manufacturers on this important work."

Bachem is a global leader in the development and manufacture of peptide and oligonucleotide APIs, supplying pharmaceutical and biotechnology companies around the world. As demand for peptide therapeutics, including those used in GLP-1 medicines, and other critical medications continues to accelerate, the growth of pharmaceutical manufacturing is bringing increasing attention to environmental stewardship.

Trifluoroacetic acid (TFA), an ultra-short-chain PFAS, is receiving increasing regulatory attention in Europe and the United States. European authorities are evaluating broader PFAS restrictions under the REACH framework, while the U.S. Environmental Protection Agency has proposed including TFA in the Sixth Unregulated Contaminant Monitoring Rule (UCMR 6) for nationwide drinking water monitoring.

Against this evolving regulatory backdrop, Bachem has taken a proactive approach by deploying ClarosTechUV™ to support the responsible and sustainable use of PFAS substances necessary for essential pharmaceutical applications, while addressing TFA in its industrial wastewater at the source and helping future-proof its production of essential products against an evolving global regulatory landscape. ClarosTechUV™ is designed to fit within existing treatment trains, enabling manufacturers to add PFAS destruction capability without changing their entire treatment setup.

Unlike conventional PFAS treatment technologies that often require additional management and disposal, the patented ClarosTechUV™ PFAS Destruction System is designed to permanently destroy PFAS at the source—including ultra-short-chain PFAS such as TFA—through an on-site, low-footprint, proprietary high-flow UV photochemical process engineered for industrial wastewater treatment.

The Claros pilot forms part of Bachem's broader commitment to reducing TFA in its industrial wastewater and advancing more environmentally responsible pharmaceutical manufacturing. In a recent article published by the Swiss newspaper Volksstimme detailing the Claros pilot, Patrick Barth, Head Group Communications at Bachem, said that following ClarosTechUV™ treatment of Bachem's industrial wastewater, "only very low residual concentrations of TFA were detectable."

In the same article, André Casagrande, Site Manager at Bachem's Bubendorf campus, placed the company's work with Claros within Bachem's broader approach to responsible pharmaceutical manufacturing. "Innovation and environmental responsibility go hand in hand for us," Casagrande said. "We want not only to help people through our products, but also to play a responsible role with regard to the environment."

Engineered for the Next Generation of Pharmaceutical Manufacturing

The ClarosTechUV™ system is engineered specifically for high-flow industrial operations and designed to integrate seamlessly into existing manufacturing wastewater systems. Unlike conventional technologies that separate PFAS into secondary waste streams requiring ongoing management and disposal, ClarosTechUV™ permanently destroys PFAS for good. The Bachem pilot generated operating data under full manufacturing conditions to inform engineering and design decisions for a commercial system.

About Bachem AG

Bachem is a leading, innovation-driven company specializing in the development and manufacture of peptides and oligonucleotides. The company, which has over 50 years of experience and expertise, provides products for research, clinical development, and commercial application to pharmaceutical and biotechnology companies worldwide and offers a comprehensive range of services. Bachem operates internationally with its headquarters in Switzerland and sites in Europe, the US and Asia. The company is listed on the SIX Swiss Exchange (SIX: BANB).

For more information, visit Bachem.

About Claros Technologies

Founded in 2018 and based in Minneapolis, Claros Technologies deploys PFAS destruction solutions across industrial wastewater, groundwater, data center water, and municipal wastewater applications. The company operates through two core divisions: ClarosTech™ delivers permanent PFAS destruction through commercially available, high-flow UV-based systems that permanently destroy 99.99% of target PFAS species—long, short, and ultra-short chains; and ClarosLabs™, its ISO/IEC 17025:2017-accredited analytical division and leading commercial laboratory specializing in PFAS detection, quantification, and exposure assessment.

Claros is on a mission to take the "forever" out of "forever chemicals" and destroy PFAS for good.

For more information, visit Claros Technologies.

Media Contact for Claros Technologies

Kari Finkler

Marketing & Communications Director

Email: [email protected]

Share this article

New Silicon Valley facility expands Autel Energy's North American presence while new partnership brings "amenity-as-a-service" to EV charging sites

FREMONT, Calif., Sept. 22, 2026 /PRNewswire/ -- Autel Energy, a global provider of electric vehicle charging solutions, today celebrates the opening of its new North American Experience Center in Fremont, California, bringing together industry leaders, public officials, customers and partners for a ribbon-cutting ceremony marking the company's continued investment in the North American EV charging market.

The opening also kicks off Autel Energy's 2026 North American Partner Summit, taking place September 23–24 at the new facility and bringing together an impressive network of charging industry professionals representing distributors, resellers, charging network operators, technology providers, fleets and other organizations supporting the deployment of EV infrastructure.

As part of the opening, Autel Energy also announced a new partnership with Modal, a provider of modular, fully managed amenity pods designed specifically for EV charging sites. The partnership gives Autel Energy customers and partners a new avenue for creating charging destinations that combine reliable, high-power EV charging with amenities designed around the driver experience.

"Opening our Fremont Experience Center represents much more than adding another location," said Michelle Luo, CEO of Autel Energy North America. "It represents our commitment to our customers and partners and to building the next generation of charging infrastructure here in North America. We want this facility to be a place where the industry can experience new technology, test solutions, collaborate and ultimately accelerate the deployment of reliable EV charging."

A New Home for Collaboration, Demonstration and Training

Located in the heart of the Bay Area's technology and transportation ecosystem, the Fremont Experience Center will serve as Autel Energy's new hands-on destination for customers, partners, fleets and other industry stakeholders.

The facility showcases Autel Energy's portfolio of AC and DC charging technology and provides space for live charging demonstrations, interoperability testing, technical training and partner collaboration, as well as a service hub with ready to ship parts in stock.

The September 22 ribbon-cutting brings together leaders from government, transportation and the EV industry, with remarks from Autel Energy leadership and invited guests including California Assemblymember Alex Lee, California Energy Commissioner Nancy Skinner, Wendy Wilson of Catalyst Mobility and Mike Murphy of EVs for All America.

Commercial vehicles from Isuzu, Harbinger and Blue Bird are also being featured as part of the opening, demonstrating the increasingly diverse range of vehicles and applications being supported by modern charging infrastructure.

"Fremont gives us an opportunity to bring the entire charging ecosystem together in one place," said Shane Long, President of Autel Energy North America. "Customers can see the equipment operating, partners can work directly with our teams, and vehicle manufacturers can demonstrate real-world charging. That collaboration is critical as the industry moves from individual charging projects toward infrastructure that needs to operate reliably at scale."

Bringing the Autel Energy Partner Ecosystem Together

Immediately following the ribbon-cutting and media day, Autel Energy will host its annual North American Partner Summit at the Fremont facility on September 23 and 24.

The two-day program brings together Autel Energy's growing ecosystem of hardware, software, service, distribution and deployment partners for technical sessions, product demonstrations and discussions focused on the next phase of EV infrastructure development.

Sessions will cover Autel Energy's product roadmap, open standards and OCPP software integration, service and support, Buy America and BABA requirements, weights and measures compliance, market trends and the evolving economics of EV charging deployment.

Live demonstrations will allow attendees to see Autel Energy charging systems operating with commercial electric vehicles and explore technologies designed for applications ranging from workplace and multifamily charging to fleet depots and high-power public charging.

"The Partner Summit is important because no single company builds the charging ecosystem by itself," said Luo. "Hardware, software, vehicles, service, distribution, site development and operations all have to work together. Our strategy is to remain open and partner-friendly so our customers can assemble the solutions that make the most sense for their projects."

About Autel Energy

Autel Energy designs and manufactures EV charging hardware for residential, commercial, fleet and public applications worldwide. The company's portfolio spans AC charging, DC fast charging and high-power charging solutions designed around reliability, interoperability and open standards. Through its North American operations, Autel Energy supports customers and partners with product development, testing, training, technical support and charging infrastructure solutions for a rapidly evolving transportation market.

SOURCE Autel Energy North America

Share this article